TRIPTORELIN

triptorelin 22.5 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack

TRIPTORELIN (5297T)

triptorelin 22.5 mg injection [1 vial] (&) inert substance diluent [2 mL ampoule], 1 pack
5297T
Body System:
Manner of administration:Injection
General Schedule
Restricted Benefit

Restriction

Indication: Locally advanced (stage C) or metastatic (stage D) carcinoma of the prostate

Restriction

Indication: Central precocious puberty
Treatment phase: Initial treatment

Restriction

Indication: Central precocious puberty
Treatment phase: Continuing treatment with this drug, or, switching gonadotropin releasing hormone analogue therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,377.57 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Diphereline